IRIS PubliCatt

Ferraccioli, Gianfranco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.129
EU - Europa 6.899
AS - Asia 2.417
SA - Sud America 42
AF - Africa 38
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 22
Totale 16.571
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.067
DE - Germania 1.810
CN - Cina 1.140
SE - Svezia 1.059
IT - Italia 848
PL - Polonia 734
UA - Ucraina 665
SG - Singapore 610
FR - Francia 606
IE - Irlanda 380
GB - Regno Unito 233
ID - Indonesia 230
FI - Finlandia 198
IN - India 166
RU - Federazione Russa 141
TR - Turchia 94
BE - Belgio 89
CA - Canada 52
HK - Hong Kong 45
JP - Giappone 38
IR - Iran 36
AU - Australia 22
CI - Costa d'Avorio 21
NL - Olanda 19
CH - Svizzera 17
BR - Brasile 13
CL - Cile 13
RO - Romania 13
VN - Vietnam 13
CZ - Repubblica Ceca 12
EU - Europa 12
ES - Italia 11
DK - Danimarca 10
A2 - ???statistics.table.value.countryCode.A2??? 8
LT - Lituania 8
ZA - Sudafrica 8
NO - Norvegia 7
CO - Colombia 6
GR - Grecia 6
KR - Corea 6
LK - Sri Lanka 6
MX - Messico 6
SA - Arabia Saudita 6
AR - Argentina 5
BG - Bulgaria 5
IL - Israele 5
AT - Austria 4
EC - Ecuador 4
LV - Lettonia 4
TW - Taiwan 4
BD - Bangladesh 3
EE - Estonia 3
EG - Egitto 3
HU - Ungheria 3
IQ - Iraq 3
LA - Repubblica Popolare Democratica del Laos 3
NG - Nigeria 3
SI - Slovenia 3
A1 - Anonimo 2
LU - Lussemburgo 2
NZ - Nuova Zelanda 2
PA - Panama 2
PT - Portogallo 2
SC - Seychelles 2
TH - Thailandia 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CR - Costa Rica 1
CY - Cipro 1
GE - Georgia 1
HR - Croazia 1
MD - Moldavia 1
MK - Macedonia 1
MY - Malesia 1
PH - Filippine 1
PK - Pakistan 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
UG - Uganda 1
UZ - Uzbekistan 1
Totale 16.571
Salva come PNG Salva come JPEG
Città #
Chandler 1.287
Warsaw 602
Ashburn 519
Singapore 464
Ann Arbor 390
Jacksonville 388
Dearborn 371
Dublin 363
San Mateo 318
Wilmington 287
Fairfield 273
Nanjing 249
Woodbridge 238
Jakarta 228
Cattolica 178
Houston 178
Seattle 168
Boston 150
Lawrence 140
New York 132
Kraków 121
Beijing 111
Milan 107
Moscow 103
Redwood City 92
Bremen 91
Marseille 85
Cambridge 83
Brussels 82
Izmir 81
Nürnberg 81
Munich 78
Nanchang 76
Rome 70
Princeton 68
Kunming 61
Norwalk 57
Boardman 55
Lancaster 53
Pune 52
Mountain View 50
Helsinki 47
Hebei 46
Hong Kong 45
Shenyang 43
Guangzhou 41
Chicago 37
Los Angeles 37
University Park 37
Hangzhou 36
Redmond 35
Tianjin 35
Falls Church 31
Hefei 28
Jiaxing 27
Changsha 26
London 26
Shanghai 26
Toronto 24
Zhengzhou 24
Detroit 23
Fremont 23
Jinan 22
Abidjan 21
Leawood 21
Andover 20
Augusta 19
Paris 17
Busto Arsizio 15
Frankfurt am Main 14
Fuzhou 13
Ningbo 13
San Diego 13
Simi Valley 13
Phoenix 12
Washington 12
Dong Ket 11
Kish 11
Tokyo 11
Ardabil 10
Ottawa 10
Santa Maria 10
Chengdu 9
Costa Mesa 9
Florence 9
Haikou 9
Perth 9
Changchun 8
Clearwater 8
Lanzhou 8
Torino 8
Edinburgh 7
Xian 7
Zurich 7
Bari 6
Copenhagen 6
Dallas 6
Forest City 6
Herenthout 6
Melbourne 6
Totale 9.699
Salva come PNG Salva come JPEG
Nome #
Porphyromonas gingivalis and the pathogenesis of rheumatoid arthritis: analysis of various compartments including the synovial tissue 382
Modeling the ternary complex TCR-Vbeta/CollagenII(261-273)/HLA-DR4 associated with rheumatoid arthritis. 337
The prognostic significance of the Birmingham Vasculitis Activity Score (BVAS) with systemic vasculitis patients transferred to the intensive care unit (ICU) 322
MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritis 299
Overweight/obesity affects histological features and inflammatory gene signature of synovial membrane of Rheumatoid Arthritis 273
Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis 261
B CELL DEPLETION IN DIFFUSE PROGRESSIVE SYSTEMIC SCLEROSIS: SAFETY, SKIN SCORE MODIFICATION AND IL-6 MODULATION IN AN UP TO THIRTY-SIX MONTHS FOLLOW-UP OPEN-LABEL TRIAL 241
MicroRNA-155-at the Critical Interface of Innate and Adaptive Immunity in Arthritis. 207
B cell subsets in the joint compartments of seropositive and seronegative RA and non-RA arthritides express memory markers and ZAP-70 and characterize the aggregate pattern irrespectively of the autoantibody status. 194
Impatto dell’inquinamento ambientale da benzene e PM10 sulla progressione clinica della sclerosi sistemica: un’analisi di correlazione. 184
Proteomic study of salivary peptides and proteins in patients with Sjögren's syndrome before and after pilocarpine treatment 176
Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis. 167
MR imaging of atlantoaxial joint in early rheumatoid arthritis. 164
Allocare risorse nel settore di farmaci biologici: il caso di Etanercept per il trattamento dell’artrite reumatoide 156
Septic sacroiliitis: an uncommon septic arthritis 149
Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: Potential utility of immunosuppressive therapy in cardiac damage progression 145
MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis 139
Proteomic approaches to Sjögren's syndrome: a clue to interpret the pathophysiology and organ involvement of the disease. 138
B-cell subsets in the joint compartments of seropositive and seronegative rheumatoid arthritis (RA) and No-RA arthritides express memory markers and ZAP70 and characterize the aggregate pattern irrespectively of the autoantibody status 138
Porphyromonas gingivalis and the pathogenesis of rheumatoid arthritis: analysis of various compartments including the synovial tissue. 137
A vascular endothelial growth factor deficiency characterises scleroderma lung disease 136
Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis 135
Atlantoepistrophic magnetic resonance imaging involvement in early rheumatoid arthritis: an aggressive tight control therapy not fully arresting the disease 134
Collagen-specific T cell repertoire in blood and synovial fluid varies with disease activity in Early Rheumatoid Arthritis. 132
Systematic review of the literature and a case report informing biopsy-proven giant cell arteritis (GCA) with normal C-reactive protein 130
Very early rheumatoid arthritis is the major predictor of major outcome: clinical ACR remission and radiographic non-progression. 126
beta-thymosins and interstitial lung disease: study of a scleroderma cohort with a one-year follow-up 125
The role of High-mobility group box protein 1 in collagen antibody-induced arthritis is dependent on Vascular endothelial growth factor. 125
Modeling the Ternary Complex TCR-V beta/CollagenII(261-273)/HLA-DR4 Associated with Rheumatoid Arthritis 124
Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks 123
ZAP-70+ B Cell Subset Influences Response to B Cell Depletion Therapy and Early Repopulation in Rheumatoid Arthritis 122
B CELLS IN SYSTEMIC SCLEROSIS: A POSSIBLE TARGET FOR THERAPY 120
Proton pump inhibitors in rheumatic diseases: clinical practice, drug interactions, bone fractures and risk of infections 119
Cilostazol improves the response to ischemia in diabetic mice by a mechanism dependent on PPARγ. 119
Memory B cell subsets and plasmablasts are lower in early than in long-standing rheumatoid arthritis 119
Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis 116
Detection of bone erosions in early rheumatoid arthritis: 3D ultrasonography versus computed tomography 115
Body weight, gender and response to TNF-α blockers in axial spondyloarthritis 113
Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis 111
Preliminary classification criteria for the cryoglobulinaemic vasculitis 111
Proteome analysis of biological fluids from autoimmune-rheumatological disorders 109
ENVIRONMENTAL POLLUTION AND SYSTEMIC SCLEROSIS: A PILOT STUDY ON BENZENE AND PARTICULATE EXPOSURE AS RISK FACTORS FOR THE SYSTEMIC MANIFESTATIONS 109
Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse Outcome 108
An autosomal recessive DNASE1L3-related autoimmune disease with unusual clinical presentation mimicking systemic lupus erythematosus 108
Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk 106
New therapeutic effects of cilostazol in patients with ischemic disorders. 103
Tapering and discontinuation of TNF-α blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remission 102
The potential role of Th17 in mediating the transition from acute to chronic autoimmune inflammation: rheumatoid arthritis as a model. 99
Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse Outcome 99
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease 99
A paraneoplastic retroperitoneal fibrosis resistant to corticosteroids treated with tamoxifen. 97
Clinical and ultrasonographic remission determines different chances of relapse in early and long standing rheumatoid arthritis. 97
Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: A clue to interpret different chances of relapse after clinical remission? 94
Chemerin and PEDF are metaflammation-related biomarkers of disease activity and obesity in rheumatoid arthritis 91
Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks 90
PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis 89
Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk 89
Haemophilus parasuis (Glaesserella parasuis) as a Potential Driver of Molecular Mimicry and Inflammation in Rheumatoid Arthritis 89
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 88
Artrite reumatoide. Terapia 88
Environmental pollution and systemic sclerosis manifestations: a pilot study on benzene and particulate exposure 87
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 87
Quantitative and semi-quantitative computed tomography analysis of interstitial lung disease associated with systemic sclerosis: A longitudinal evaluation of pulmonary parenchyma and vessels 87
Life-threatening arrhythmias in a scleroderma patient: the role of myocardial inflammation in arrhythmic outburst 85
Biomolecular features of inflammation in obese rheumatoid arthritis patients: management considerations 85
Body weight, gender and response to TNF-α blockers in axial spondyloarthritis 85
Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy 84
Biomarkers of Good EULAR Response to the B Cell Depletion Therapy in All Seropositive Rheumatoid Arthritis Patients: Clues for the Pathogenesis 84
Baseline shoulder ultrasonography is not a predictive marker of response to glucocorticoids in patients with polymyalgia rheumatica: A 12-month followup study 83
Synovial tissue derived characteristics are included in a nomogram for the prediction of treatment response in naïve Rheumatoid Arthritis 83
Cilostazol improves the response to ischemia in diabetic mice by a mechanism dependent on PPARγ. 81
Improved Endothelial Function After Endothelin Receptor Blockade in Patients With Systemic Sclerosis 80
Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression 80
Is Citrullination Required for the Presence of Restricted Clonotypes Reacting With Type II Collagen? Comment on the Article by Chemin et al 79
Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study 79
Polimialgia reumatica ed arterite temporale di Horton 78
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 77
Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression. 77
Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus 76
The metabolic syndrome: the crossroads between rheumatoid arthritis and cardiovascular risk 75
Toll-like receptor 4 mediates endothelial cell activation through NF-κB but is not associated with endothelial dysfunction in patients with rheumatoid arthritis 75
Immunosuppressive Therapy (Methotrexate or Cyclophosphamide) in Combination with Corticosteroids in the Treatment of Giant Cell Arteritis: Comparison with Corticosteroids Alone 73
Selective Inhibitors of T Cell Receptor Recognition of Antigen–MHC Complexes for Rheumatoid Arthritis 73
Body mass index and treatment response to subcutaneous abatacept in patients with psoriatic arthritis: A post hoc analysis of a phase III trial 73
The human salivary proteome: a critical overview of the results obtained by different proteomic platforms 72
Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases) 72
Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study 71
Polymorphisms of the IgH enhancer HS1.2 and risk of systemic lupus erythematosus 71
Systemic Bone Density at Disease Onset Is Associated With Joint Erosion Progression in Early Naive to Treatment Rheumatoid Arthritis: A Prospective 12-Month Follow-Up Open-Label Study 70
Validation of the classification criteria for cryoglobulinaemic vasculitis 69
Thymosin β4 and β10 in Sjögren's syndrome: Saliva proteomics and minor salivary glands expression 69
CTLA-4 Ig as an effective treatment in a patient with type I diabetes mellitus and seropositive rheumatoid arthritis 68
Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis. 67
Association between the response to B cell depletion therapy and the allele*2 of the HS1,2A enhancer in seropositive rheumatoid arthritis patients 67
CTLA-4 Ig as an effective treatment in a patient with type I diabetes mellitus and seropositive rheumatoid arthritis 67
New therapeutic effects of cilostazol in patients with ischemic disorders 67
Adiposity, joint and systemic inflammation: the additional risk of having a metabolic syndrome in rheumatoid arthritis 66
Rheumatoid arthritis and Alzheimer's disease: genetic and epigenetic links in inflammatory regulation 65
Is it necessary to be citrullinated to have restricted clonotypes reacting with Collagen type II? Comment to article "A novel HLA-DRB1*10:01 restricted T cell epitope from citrullinated type II collagen relevant for Rheumatoid Arthritis" 64
Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy 64
Totale 11.633
Salva come PNG Salva come JPEG
Categoria #
all - tutte 73.385
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.385
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.075 0 0 0 0 0 0 239 131 123 144 253 185
2020/20211.919 129 189 261 165 230 89 167 38 239 106 255 51
2021/20221.961 219 158 60 102 131 75 69 296 92 141 272 346
2022/20233.649 461 485 283 597 262 434 151 323 416 45 115 77
2023/20241.773 85 543 67 76 50 243 125 94 18 52 270 150
2024/2025988 73 93 294 118 323 87 0 0 0 0 0 0
Totale 16.852